Masakazu Nagahori Selected Research

Masakazu Nagahori Research Topics

Disease

15	Ulcerative Colitis 01/2023 - 01/2007
10	Crohn Disease (Crohn's Disease) 01/2023 - 03/2011
4	Inflammation (Inflammations) 01/2023 - 12/2018
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2022 - 02/2013
3	Colitis 02/2023 - 01/2016
3	Neoplasms (Cancer) 01/2021 - 01/2016
3	Disease Progression 07/2019 - 04/2018
2	Necrosis 10/2023 - 09/2019
2	Infections 01/2021 - 05/2013
1	Stomach Ulcer (Gastric Ulcer) 04/2023
1	Hematemesis 04/2023
1	Behcet Syndrome (Behcet's Syndrome) 04/2023
1	Peptic Ulcer (Peptic Ulcers) 04/2023
1	Ulcer 02/2023
1	Ischemic Colitis 02/2023
1	Cytomegalovirus Infections (Inclusion Disease) 02/2023
1	Fatigue 01/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2022
1	Injection Site Reaction 10/2021
1	Hemorrhage 01/2021
1	Leukopenia 10/2019
1	Acute Disease 06/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019
1	Herpesviridae Infections (Herpesvirus Infection) 01/2019
1	Hyperplasia 01/2019
1	Primary Immunodeficiency Diseases 01/2019
1	Intestinal Diseases (Diseases, Intestinal) 12/2018
1	Intestinal Failure 04/2018
1	Colorectal Neoplasms (Colorectal Cancer) 04/2018
1	Adenocarcinoma 03/2018
1	Clostridium Infections 03/2017
1	Opportunistic Infections (Opportunistic Infection) 07/2015
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 07/2015
1	Human Influenza (Influenza) 05/2013
1	Rubella (German Measles) 02/2013
1	Herpes Zoster 02/2013
1	Chickenpox 02/2013
1	Measles 02/2013
1	Mumps 02/2013
1	Muscular Diseases (Myopathy) 01/2007

Drug/Important Bio-Agent (IBA)

4	2-mercaptopurineIBA 10/2023 - 05/2013
4	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2023 - 01/2007
4	Adalimumab (Humira)FDA Link 10/2019 - 11/2016
3	SteroidsIBA 10/2023 - 05/2013
3	Infliximab (Remicade)FDA Link 04/2023 - 07/2018
3	vedolizumabIBA 04/2022 - 01/2021
3	Tacrolimus (Prograf)FDA LinkGeneric 12/2021 - 01/2014
3	Azathioprine (Imuran)FDA LinkGeneric 09/2019 - 11/2016
3	Immunologic Factors (Immunomodulators)IBA 05/2013 - 03/2011
2	CytokinesIBA 10/2021 - 01/2016
2	Mesalamine (Mesalazine)FDA LinkGeneric 01/2021 - 04/2017
2	AntibodiesIBA 01/2020 - 02/2013
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 06/2019 - 12/2018
1	Colchicine FDA LinkGeneric 04/2023
1	Eplerenone (Inspra)FDA LinkGeneric 02/2023
1	Ganciclovir (Cytovene)FDA LinkGeneric 02/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Leucine (L-Leucine)FDA Link 01/2023
1	OF 900IBA 01/2022
1	tofacitinibIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Diphosphates (Pyrophosphates)IBA 10/2019
1	NucleosidesIBA 10/2019
1	Monoclonal AntibodiesIBA 09/2019
1	DiamondIBA 09/2019
1	CholesterolIBA 06/2019
1	AlbuminsIBA 06/2019
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2019
1	MucinsIBA 03/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	InterleukinsIBA 01/2016
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2016
1	Calcineurin InhibitorsIBA 07/2015
1	Estrogens (Estrogen)FDA Link 01/2014
1	IsoflavonesIBA 01/2014
1	Antiviral Agents (Antivirals)IBA 05/2013
1	ImmunosorbentsIBA 02/2013
1	EnzymesIBA 02/2013
1	Immunoglobulin G (IgG)IBA 02/2013
1	Prednisolone (Predate)FDA LinkGeneric 01/2007
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2007

Therapy/Procedure

13	Therapeutics 10/2023 - 01/2008
2	Restorative Proctocolectomy 01/2023 - 01/2007
2	Colectomy 01/2021 - 04/2018
1	Aftercare (After-Treatment) 01/2020
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Salvage Therapy 01/2014